BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23187165)

  • 1. Reactivation of herpes zoster keratitis in an adult after varicella zoster vaccination.
    Hwang CW; Steigleman WA; Saucedo-Sanchez E; Tuli SS
    Cornea; 2013 Apr; 32(4):508-9. PubMed ID: 23187165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes zoster stromal keratitis after varicella vaccine booster in a pediatric patient.
    Krall P; Kubal A
    Cornea; 2014 Sep; 33(9):988-9. PubMed ID: 25062334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of Herpes Zoster Keratitis With Corneal Perforation After Zoster Vaccination.
    Jastrzebski A; Brownstein S; Ziai S; Saleh S; Lam K; Jackson WB
    Cornea; 2017 Jun; 36(6):740-742. PubMed ID: 28410358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel vaccine (Zostavax) to prevent herpes zoster.
    Holcomb K; Weinberg JM
    G Ital Dermatol Venereol; 2008 Apr; 143(2):119-23. PubMed ID: 18833038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes zoster virus sclerokeratitis and anterior uveitis in a child following varicella vaccination.
    Naseri A; Good WV; Cunningham ET
    Am J Ophthalmol; 2003 Mar; 135(3):415-7. PubMed ID: 12614776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster.
    Mills R; Tyring SK; Levin MJ; Parrino J; Li X; Coll KE; Stek JE; Schlienger K; Chan IS; Silber JL
    Vaccine; 2010 Jun; 28(25):4204-9. PubMed ID: 20416263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes zoster keratouveitis and inflammatory ocular hypertension 8 years after varicella vaccination.
    Lin P; Yoon MK; Chiu CS
    Ocul Immunol Inflamm; 2009; 17(1):33-5. PubMed ID: 19294571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratitis in association with herpes zoster and varicella vaccines.
    Grillo AP; Fraunfelder FW
    Drugs Today (Barc); 2017 Jul; 53(7):393-397. PubMed ID: 28837183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination: a new option to reduce the burden of herpes zoster.
    Mick G
    Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivation of Herpes Zoster Stromal Keratitis After HZ/su Adjuvanted Herpes Zoster Subunit Vaccine.
    Lehmann A; Matoba A
    Ophthalmology; 2018 Nov; 125(11):1682. PubMed ID: 30318037
    [No Abstract]   [Full Text] [Related]  

  • 11. Acyclovir therapy in herpes zoster infection. A practical guide.
    McGill J; Chapman C; Mahakasingam M
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 1)():111-4. PubMed ID: 6362108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes zoster in older adults.
    Cadogan MP
    J Gerontol Nurs; 2010 Mar; 36(3):10-4. PubMed ID: 20302254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of herpes zoster by vaccination].
    Kofoed K; Rønholt F; Gerstoft J; Sand C
    Ugeskr Laeger; 2011 Jan; 173(2):110-4. PubMed ID: 21219841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
    Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late reactivation of herpes zoster keratitis results in band keratopathy.
    Albietz JM; Lenton LM
    Optom Vis Sci; 2014 Jun; 91(6):e149-55. PubMed ID: 24811851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.
    Liesegang TJ
    Ophthalmology; 2008 Feb; 115(2 Suppl):S3-12. PubMed ID: 18243930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes zoster peripheral ulcerative keratitis in patients with the acquired immunodeficiency syndrome.
    Neves RA; Rodriguez A; Power WJ; Muccioli C; Lane L; Belfort R; Foster CS
    Cornea; 1996 Sep; 15(5):446-50. PubMed ID: 8862919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, humoral and cell-mediated immune responses to herpes zoster vaccine in subjects with diabetes mellitus.
    Hata A; Inoue F; Yamasaki M; Fujikawa J; Kawasaki Y; Hamamoto Y; Honjo S; Moriishi E; Mori Y; Koshiyama H
    J Infect; 2013 Sep; 67(3):215-9. PubMed ID: 23603250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presumed Herpes Zoster Ophthalmicus Reactivation Following Recombinant Zoster Vaccination.
    Jabbour S; Shekhawat NS; Chen A; Woreta FA
    Cornea; 2021 Feb; 40(2):248-250. PubMed ID: 32947398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
    Lu PJ; Euler GL; Jumaan AO; Harpaz R
    Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.